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Abstract 50 
 51 
The gut microbiota plays a pivotal role in the conversion of dietary flavonoids, which can affect their 52 
bioavailability and bioactivity and thereby their health-promoting properties. The ability of 53 
flavonoids to stimulate the activity of the microbiota has, however, not been systematically evaluated. 54 
In the present study, we used a fluorescence-based single-cell activity measure [biorthogonal non-55 
canonical ammino acid-tagging (BONCAT)] combined with fluorescence-activated cell-sorting 56 
(FACS) to determine which microorganisms are stimulated by the flavonoid rutin. We performed 57 
anaerobic incubations of human fecal microbiota amended with rutin and in the presence of the 58 
cellular activity marker L-Azidohomoalanine (AHA) to detect rutin-stimulated cells. We found that 59 
7% of cells in the gut microbiota were active after a 6 h incubation and 23% after 24 h. We then 60 
sorted BONCAT-positive cells and observed an enrichment of Lachnospiraceae (Lachnoclostridium, 61 
and Eisenbergiella), Enterobacteriaceae, Tannerellaceae and Erysipelotrichaceae species in the 62 
rutin-responsive fraction of the microbiota. There was marked inter-individual variability in the 63 
appearance of rutin conversion products after incubation with rutin. Consistent with this, there was 64 
substantial variability in the abundance of rutin-responsive microbiota among different individuals. 65 
Specifically, we observed that Enterobacteriaceae were associated with conversion of rutin into 66 
quercetin-3-glucoside and Lachnospiraceae were associated with quercetin production. This suggests 67 
that individual microbiotas differ in their ability to metabolize rutin and utilize different conversion 68 
pathways. 69 
 70 
Introduction 71 
Flavonoids are a group of bioactive polyphenolic compounds present in a wide variety of plant-based 72 
foodstuffs.  Rutin (quercetin-3-O-rutinoside) is a flavonol glycoside composed of quercetin and 73 
rutinose, a disaccharide of rhamnose and glucose. Dietary sources of rutin include tea, green 74 
asparagus, onions, buckwheat, wine, eucalyptus, apples, as well as berries (de Araujo et al., 2013; 75 
Kumar and Pandey, 2013; Amaretti et al., 2015).  Rutin has been shown to have anti-oxidant 76 
properties (Ghorbani, 2017) and to exert anti-aging effects on human dermal 77 
fibroblasts and human skin (Choi et al., 2016). It also has anti-neurodegenerative properties 78 
(Enogieru et al., 2018) and exhibits protective effects against hyperglycemia, dyslipidemia, liver 79 
damage, and cardiovascular disorders (Ghorbani, 2017).  Additionally, the rutin degradation products 80 
quercetin-3-glucoside and quercetin have been found to have anti-inflammatory, anti-oxidant and 81 
anti-mutagenic properties (Gibellini et al., 2011; Kumar and Pandey, 2013; Hobbs et al., 2018). 82 
Quercetin-3-glucoside also possesses  anti-hypotensive, hypolipidemic effects (Gibellini et al., 2011; 83 
Kumar and Pandey, 2013; Hobbs et al., 2018) and quercetin has been reported to ameliorate 84 
atherosclerosis and dyslipidemia (Salvamani et al., 2014). 85 
 86 
The bioavailability of these dietary flavonoids depends on intestinal absorption, which is determined 87 
by their chemical composition and, in particular, by the nature of glycosylation (Matsumoto et al., 88 
2004). The glyco-conjugates of quercetin are poorly absorbed in the upper intestinal tract and 89 
accumulate in the large intestine. In the colon, members of the gut microbiota can hydrolyze rutin or 90 
other glyco-conjugates, removing the sugar moiety and permitting the absorption of the aglycone 91 
(Cardona et al., 2013; Amaretti et al., 2015). Therefore, the colonic microbiota is responsible for the 92 
extensive breakdown of the original flavonoid structures into low-molecular-weight phenolic 93 
metabolites (Cardona et al., 2013). Currently, it is estimated that 500–1000 different microbial species 94 
inhabit the gastrointestinal tract, reaching the highest concentration in the colon (up to 1012 cells per 95 
gram of faeces) (Thursby and Juge, 2017). Bacteria that metabolize rutin possess α-rhamnosidases 96 
that transform rutin into quercetin-3-glucoside and/or β-glucosidases that either convert quercetin-3-97 
glucoside into quercetin (Braune and Blaut, 2016) or convert rutin directly into quercetin (Olthof et 98 
al., 2003). A limited number of bacteria have so-far been shown to have rutin-metabolizing 99 
capabilities in pure culture. α-rhamnosidases involved in deglycosylation of flavonoids have been 100 
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characterized in Lactobacillus acidophilus, Lactobacillus plantarum (Beekwilder et al., 2009) and 101 
Bifidobacterium dentium (Bang et al., 2015).The capability to degrade rutin into quercetin was 102 
reported for Bacteroides uniformis, Bacteroides ovatus (Bokkenheuser et al., 1987), and 103 
Enterobacterium avium (Shin et al., 2016). Parabacteroides distasonis was shown produce both 104 
quercetin-3-glucoside and quercetin via α-rhamnosidase and β-glucosidase activity (Bokkenheuser et 105 
al., 1987), and Eubacterium ramulus and Enterococcus casseliflavus are able to convert quercetin-3-106 
glucoside in quercetin (Schneider et al., 1999). 107 
 108 
Previous studies of rutin conversion by gut bacteria have involved screening strain collections, which 109 
gives limited insight into identifying which bacteria are actually involved in metabolizing rutin in the 110 
complex gut microbial community. In the present study, we identified rutin-stimulated cells in the 111 
gut microbiota by performing anaerobic incubations of human fecal microbiota amended with rutin 112 
in the presence of the cellular activity marker L-Azidohomoalanine (AHA). By sorting active cells 113 
and profiling active and total communities using 16S rRNA gene amplicon sequencing we were able 114 
to identify specific taxa enriched in rutin-treated samples. We observed marked inter-individual 115 
variability in both the extent of rutin degradation product formation as well as the abundance of the 116 
rutin-responsive microbial community. Our findings present new insights into rutin metabolism by 117 
different microbiotas in healthy individuals, which will be useful for future studies on flavonol 118 
metabolism in health as well as in disease conditions.  119 
 120 
Material and methods 121 
 122 
Sample collection  123 
Fresh faecal samples were collected from 10 healthy subjects (7 females and 3 males, age mean±SD 124 
:30.5±5.8; BMI:mean ±SD: 22.19±2.9). All participant followed an omnivore diet. Participants with 125 
antibiotic, probiotic, or prebiotic usage in the previous six months were excluded. The study was 126 
approved by, and conducted in accordance, with the University of Vienna ethics committee 127 
(Reference number 00161) and written informed consent was signed by all enrolled participants. 128 
 129 
Anaerobic incubations 130 
Fresh stool samples were immediately introduced into an anaerobic tent. Phosphate-buffered saline 131 
(PBS) was added to the sample to arrive to a concentration of 1 g/10 ml. The suspension was 132 
homogenized by vigorous shaking and vortexing. Samples were left for 15 minutes to allow large 133 
particles to settle and subsequentally serially-diluted 1:10 twice. Samples were incubated in 134 
autoclaved Hungate tubes in the presence of 1 mM of the non-canonical amino acid L-135 
azidohomoalanine (AHA) (baseclick GmbH, Germany) and 500µM rutin dissolved in dimethyl 136 
sulfoxide (DMSO; Sigma-Aldrich). A negative control containing DMSO and a positive control with 137 
2 mg/ml of glucose were used for each experiment. An abiotic control for each time point was 138 
included to assess the chemical stability of rutin under the incubation conditions. Samples were 139 
incubated under anaerobic condition with a final volume of 5 ml for 0, 6 or 24 hours. Subsequently, 140 
samples were centrifuged at 14,000 rpm for 10 min and the supernatant was collected and diluted 141 
with equal volume of pure acetonitrile (ACN) in order to stabilize the supernatant samples and then 142 
stored at -20 C for LC-HRMS analysis. Part of the sample was frozen for nucleic acid extraction and 143 
part was washed twice in PBS and then fixed in 1:1 ethanol:PBS for FACS sorting.  144 
 145 
Liquid chromatography-high resolution mass spectrometry (LC-HRMS) 146 
Acetonitrile (LC-MS grade) and formic acid were purchased from VWR. High purity water (18,2 147 
MW cm-1) was used for dilution of samples and the preparation of mobile phases (Milli-Q 148 
Synergy/Elix water purification system, Merck). Authentic reference standards of rutin and quercetin 149 
were purchased from Sigma-Aldrich (> 94%, HPLC) and Extrasynthese (> 99%, HPLC) respectively. 150 
Supernatants from the incubations were immediately centrifuged and aliquots for HPLC analysis was 151 
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removed and equal volume of CAN was added. Samples were kept frozen until analysis. The ACN-152 
stabilized samples were thawed and homogenized by vortexing. 100 µl was diluted 1:4 in water to 153 
decrease acetonitrile content to 10%. The diluted sample was filtered through a 0.22 µm pore 154 
polytetrafluoroethylene syringe filter (Cronus, LabHut Ltd.), and 5 uL were injected into the LC 155 
system. Chromatographic separation was achieved on a Phenomenex Kinetex EVO C18 100 x 2.1 156 
mm, 2.6 µm column utilizing an Agilent 1200 HPLC system. The column was operated at 30°C. The 157 
binary mobile phase consisted of H2O with 0.1% formic acid (eluent A) and acetonitrile (eluent B). 158 
The flow rate was set to 0.4 mL min-1. Gradient separation was started at 5% B and linearly increased 159 
to reach 90% in 9 min. The eluent was kept constant at 90% B until 11.5 min and then the column 160 
was re-equilibrated at the initial conditions for 11.5 min. The effluent of the LC system was connected 161 
to an Agilent 6530 high-resolution, accurate mass quadrupole/time-of-flight mass spectrometer 162 
equipped with a dual sprayer electrospray ion source (ESI-Q/TOFMS). The mass spectrometry was 163 
run in full scan (MS-only) mode scanning from m/z 50-1700 in negative ionization mode. A 164 
continuous reference mass correction was applied using purine and HP-921 (Hexakis(1H,1H,3H-165 
perfluoropropoxy)phosphazene) as reference substances. The ion source temperature was maintained 166 
at 325 °C and capillary and fragmentor voltages were set to -4000 V and 140 V, respectively. The 167 
Mass Hunter Workstation software package (B02.01) was used for data acquisition and data 168 
evaluation.  169 
 170 
BONCAT labelling of microbial cells 171 
Cu(I)-catalyzed click labelling of chemically-fixed microbial cells was performed on slides as 172 
described previously  (Hatzenpichler et al., 2014). Briefly, fixed samples were immobilized on glass 173 
slides, dried in a 46°C hybridization oven, and dehydrated and permeabilized by placing slides for 3 174 
min sequentially in 50, 80 and 96% ethanol. Then, 1.25 µl of 20 mM CuSO4, 2.50 µl of 50 mM 175 
tris[(1-hydroxypropyl-1H-1,2,3-triazol-4-yl)methyl]amine (THPTA) (baseclick GmbH , Germany), 176 
and 0.30 µl of alkyne dye (in DMSO) (Jena Bioscience, Germany) were mixed and allowed to react 177 
for 3 min at room temperature (RT) in the dark. In the meantime, 12.5 µl of freshly-prepared 100 mM 178 
sodium ascorbate (Sigma-Aldrich) and 12.5 µl of 100 mM aminoguanidine hydrochloride (Sigma-179 
Aldrich) were added to 221 µl 1× PBS (pH 7.4). Then, the dye premix was added to this solution, the 180 
tube inverted once and samples were covered by 30 µl of solution. Slides were transferred into a 181 
humid chamber and incubated in the dark at RT for 30 min. Afterwards, slides were washed three 182 
times for 3 min each in 1× PBS and then treated with an increasing ethanol series (3 min each in 50, 183 
80 and 96% ethanol) and air-dried (Hatzenpichler et al., 2014).  1:1000 DNA stain, 4’, 6 diamidino-184 
2-phenylindole (DAPI) solution, (in PBS) was applied for 5 min and then slides were washed in cold 185 
MILLI-Q water (Millipore GmbH, Vienna, Austria). Samples were embedded with CitiFluor (Agar 186 
Scientific Ltd., Stansted, UK) if used immediately or stored at -20°C. Representative BONCAT 187 
pictures of a faecal sample incubated with rutin at 6 and 24h and a negative control containing 188 
dimethyl sulfoxide (DMSO) are shown in Supplementary Figure 1. For FACS sorting, in-solution 189 
click labelling was performed immediately before FACS sorting. For click labelling, 300-500 µl fixed 190 
samples were centrifuged at 10,000 rpm for 10 min and re-suspended in 96% ethanol. The pellet was 191 
left for 3 min at RT, then centrifuged 10,000 rpm for 5 min. A master mix containing the dye solution 192 
was prepared as described above. Samples were suspended in 60-100 µl of solution and incubated in 193 
the dark at RT for 30 min. Afterwards, samples were washed three times by centrifugation with 1x 194 
PBS (Hatzenpichler et al., 2014). Immediately before sorting, samples were filtered with a 35µm 195 
nylon mesh using BD tubes 12x75mm (BD, Germany).  196 
 197 
Image acquisition and analysis 198 
20-30 images were collected for each sample with an epifluoresce microscope (Zeiss-Axio-imager, 199 
Germany). Image analysis was performed using the software digital image analysis in microbial 200 
ecology (Daime) and the biovolume fraction, the fraction of BONCAT-labelled biomass (Cy5-201 
labelled) relative to the total biomass (DAPI-labelled), was calculated (Daims et al., 2006). 202 
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Fluorescence activated cell sorting (FACS) 203 
For flow cytometry sorting, bacteria were labeled in Cy5 dye as previously described, and analyzed 204 
on an ultra high-speed cell sorter MoFlo Astrios EQ (Beckman Coulter, Brea, CA, USA) using the 205 
Summit v6.2 software (Beckman Coulter). To standardize the daily measurement and to assess the 206 
size of the bacteria, calibration beads (silica beads 100, 500 and 1000 nm, Kisker Biotech, Steinfurt, 207 
Germany) having a refractive index close to biological material were recorded. The sorting of Cy5-208 
labeled bacteria was performed as follows: In a first scatter plot, the 561nm SSC Height-Log 209 
parameter was set vs. the 488nm FSC1 Height-Log parameter. To reduce electronic noise the 210 
triggering signal was set on the 561nm SSC parameter. A second dot plot 488nm FSC1-Height-Log 211 
vs. 488nm SSC-Height-Log showed in a first measurement the different sizes of the silica beads and 212 
in the following measurements the scattering of the bacteria. Bacteria were then pre-gated and 213 
displayed on a third scatter plot with 488nm SSC area log axes vs. 640nm 671/30-Area-Log axes. 214 
Cy5-positive bacteria were then sorted out into tubes with a maximum event rate of 50,000 events 215 
per second. Reanalysis of the samples showed a purity of> 99%. A overview of the gating strategy 216 
and FACS selectivity analysis are shown in Supplementary Figure 2 and 3. 217 
 218 
DNA extraction and 16S rRNA gene amplicon sequencing 219 
DNA extraction was performed for both total microbial community and the FACS-sorted fraction 220 
using the QiAmp mini DNA extraction kit (Qiagen) according to the manufacturer’s instructions. 221 
PCR amplification was performed with a two-step barcoding approach according to Herbold et al, 222 
2015 using 16S rRNA gene primers targeting most bacteria (S-D-Bact-0341-b-S-17 [5’-223 
CCTACGGGNGGCWGCAG-3’] and S-D-Bact-0785-a-A-21 [5’-224 
GACTACHVGGGTATCTAATCC-3’]. The barcoded amplicons were purified with ZR-96 DNA 225 
Clean-up Kit (Zymo Research, USA) and quantified using the Quant-iTTM PicoGreen® dsDNA Assay 226 
(Invitrogen, USA) (Herbold et al., 2015). An equimolar library was constructed by pooling samples, 227 
and the resulting library was sent for sequencing on the Illumina MiSeq platform at Microsynth AG 228 
(Balgach, Switzerland). 229 
 230 
Sequence processing and data analysis 231 
16S rRNA gene sequence data were sorted into libraries according to Herbold et al. (2015) and 232 
processed into amplicon sequence variants (ASVs) using the Divisive Amplicon Denoising 233 
Algorithm (DADA2) (Callahan et al., 2016) and classified using the RDP classifier (Wang et al., 234 
2007) as implemented in Mothur (Schloss et al., 2009). Sequencing libraries were subsampled to a 235 
smaller number of reads than the smallest library (subsampled to 1000 reads) to avoid biases related 236 
to uneven library depth. 16S rRNA gene sequence data has been deposited in the NCBI Short Read 237 
Archive under PRJNA622517. Statistical analysis was performed using R statistical software 238 
(https://www.r-project.org/). Statistical analysis to compare samples groups was performed using 239 
ANOVA, and with the R package DEseq2 (Love et al., 2014). The statistical significance of factors 240 
affecting microbiota composition was evaluated using non-parametric permutational multivariate 241 
analysis of variance (perMANOVA), significant clustering of groups was evaluated with analysis of 242 
similarities (ANOSIM), ordination was performed using redundancy analysis (RDA) and non-metric 243 
multidimensional scaling (NMDS) in the vegan package in R (Oksanen et al., 2010). Alpha and beta 244 
diversity metrics were also calculated with the vegan package. Variables are expressed as mean ± SD 245 
(standard deviation). A probability value (p-value) less than 0.05 was considered statistically 246 
significant and p-values were adjusted with the False Discovery Rate method (FDR) in the case of 247 
multiple comparison. Statistical analysis to compare producer groups was performed using ANOVA 248 
and Tukey test for multiple comparisons. 249 
 250 
 251 
 252 
 253 
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Results 254 
 255 
Biotransformation of rutin by the gut microbiota 256 
In order to characterize the biotransformation of rutin by the gut microbiota and to identify bacteria 257 
stimulated by rutin, we performed anaerobic incubations of freshly-collected stool contents amended 258 
with 500µM rutin (Figure 1). This concentration is in line with previous studies and is consistent 259 
with a reasonable dietary intake (Amaretti et al., 2015; Zamora-Ros et al., 2016). Over the course of 260 
the incubations there was a slight but not statistically-significant reduction in rutin (one-way 261 
ANOVA, p = 0.41, n = 10 Figure 2A). However, Q-glc (quercetin-3-glucoside) and Q (quercetin) 262 
appeared after incubation with biomass (p = 0.019 and 0.036 for Q-glc and Q, respectively, n = 10; 263 
Figures 2B and C), indicating that rutin was actively transformed by the gut microbiota. Low levels 264 
of Q-glc were present in all time zero samples (Figure 2B), which may be because rutin preparations 265 
were either not completely purified or chemically degraded to Q-glc during storage. Interestingly, 266 
there was substantial variation in the amount of Q-glc and Q formed during incubation with the gut 267 
microbiota, suggesting considerable inter-individual variability in the capacity to metabolize rutin by 268 
different gut microbial communities (Figure 2D and E). 269 
 270 
The core rutin-stimulated microbiota 271 
As the capacity of dietary polyphenols to modulate the activity and/or composition of the gut 272 
microbiota is still poorly understood, we aimed to identify the microbial taxa stimulated by rutin. 273 
Rutin amendment stimulated a subset of the microbiota, and active cells were detected in almost all 274 
samples after 6 h of incubation with rutin, with an increasing number after 24 h (6h: 7.3 ± 7.0%, 24h: 275 
29 ± 11.7% [mean ±SD]; t-test: p = 0.0003, n = 20) (Figure 3A,B). The diversity and the composition 276 
of the total microbial community did not change significantly during the short-term incubations 277 
(Figures 4A,B; perMANOVA, p = 0.99), indicating that the applied incubation conditions did not 278 
appreciably modify the composition of the microbiota (i.e. there was no strong “bottle effect”). 279 
However, the rutin-stimulated fraction of the community, as determined by BONCAT activity 280 
labeling and FACS sorting, was significantly different from the total community. The diversity of the 281 
active fraction was lower than the total community (ANOVA, p < 0.0001 for all tested alpha diversity 282 
metrics; Figure 4A), and the NDMS ordination showed a clear separation of samples between the 283 
total community and the active fraction (perMANOVA, p < 0.0001; ANOSIM, p = 0.001) (Figure 284 
4B). The most abundant taxa detected in the active fraction were Bacteroidaceae, 285 
Enterobacteriaceae, Lachnospiraceae, Tannerellaceae, and Ruminococcaceae (Figure 5). We found 286 
that members of the Enterobacteriaceae (Escherichia/Shigella), Tannerellaceae (Parabacteroides), 287 
Erysipelotrichaceae (Erysipelatoclostridium), and Lachnospiraceae (Lachnoclostridium and 288 
Eisenbergiella) were significantly increased in the active fraction compared to their respective total 289 
community samples (negative binomial distribution, Wald test, p<0.05, n=20). 290 
 291 
Microbial community composition is associated with rutin transformation patterns 292 
We observed that there was a large variability in the ASVs that were enriched in the active fraction 293 
of the community across the incubations from different donors. Only 13/97 and 23/91 ASVs were 294 
shared among all incubations at 6 h and 24 h, respectively (Supplementary Figure 4A,B). Consistent 295 
with this, we found that the microbial community varied significantly within participant in both the 296 
total community and active fraction (perMANOVA: p <0.0001, Supplementary Figure 4C,D), 297 
which was in line with the observation that different cell morphologies were observed in the active 298 
fraction from different donors (Figure 3B). Though stool incubations from all participants led to the 299 
production of rutin degradation products, the pattern of rutin product formation was markedly 300 
different among different participants. We therefore divided the samples into the following groups: 301 
"High Q-glc producers", "High Q producers", and "Low producers". Based on these categories, we 302 
observed a significant clustering of both total community and active fraction samples in the 303 
redundancy analysis ordination (perMANOVA, total community: p = 0.001, active fraction: p = 304 
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0.001) (Figure 6A,B). In the active fraction, we observed an enrichment of Enterobacteriaceae 305 
(Escherichia-Shigella) in High Q-glc producers, and this taxon represented the majority of sequences 306 
recovered in the active fraction by 24 h (ANOVA: 0.0002, n=50). In contrast, High Q producers had 307 
an enrichment of Lachnospiraceae (Lachnoclostridium and Eisenbergiella), which was the dominant 308 
taxon in the active fraction by 24 h (ANOVA: 0.0257, n=50). Low producers had a trend, though not 309 
statistically significant, towards enrichment in Tannerellaceae (Parabacteroides) and 310 
Erysipelotricaceae (Erysipelatoclostridium) in the active fraction (Figure 6C, Supplementary 311 
Figure 5). 312 
 313 
Discussion 314 
The gut microbiota plays a key role in the conversion of dietary flavonoids. Though conversion of 315 
flavonoids by the microbiota has gained increasing interest (Braune and Blaut, 2016), key microbial 316 
players in flavonoid metabolism remain poorly characterized (Cardona et al., 2013). In this study, we 317 
investigated metabolism of the flavonoid rutin by the human gut microbiota. Rutin conversion 318 
products were detected in all tested donor stool incubations, but there was a dramatic variation in the 319 
amount of Q-glc and Q produced by different microbiotas. This suggests inter-individual variability 320 
in preference or capability for rutin metabolism. This is in line with a previous report of high person-321 
to-person variation in the concentration of phenolic acids between 2 and 24 h incubation of stool with 322 
rutin (Jaganath et al., 2009). 323 
 324 
Alpha diversity was lower in the active fraction compared to the total community, implying that a 325 
subset of the community is stimulated by rutin. In our study, the significant bacterial taxa selected 326 
are: Lachnospiraceae (Lachnoclostridium, Eisenbergiella), Enterobacteriaceae (Escherichia), 327 
Tannerellaceae (Parabacteroides), and Erysipelotricaceae (Erysipelatoclostridium). These bacteria 328 
may represent a “core rutin-selected microbiota” in healthy individuals. Members of the 329 
Enterobacteriaceae (Escherichia coli, Escherichia fergusonii, and Enterobacter cloacae) have been 330 
previously implicated in the O-deglycosylation and dehydroxylation of different flavonoids (Miyake 331 
et al., 1997; Hur et al., 2000; Zhao et al., 2014; Braune and Blaut, 2016). In a batch culture 332 
fermentation experiment, Tzounis et al. found that catechin, a flavan-3-ol monomers, promoted the 333 
growth of  E. coli (Tzounis et al., 2008) and Duda-Chodak found that rutin does not inhibit E.coli 334 
growth (Duda-Chodak, 2012). In accordance with our findings, Parabacteroides distasonis has been 335 
shown to produce both quercetin-3-glucoside and quercetin (Bokkenheuser et al., 1987) and the 336 
Lachnospiraceae members Blautia and Eubacterium were able to convert rutin in quercetin (Kim et 337 
al., 2014) and quercetin-3-glucoside in quercetin, respectively. Based on rutin degradation capability 338 
and the identification of the core-rutin selective microbiota, we divided the donor microbiotas into 339 
high Q-glc, high Q, and low producers. We observed that members of Enterobacteriaceae 340 
(Escherichia) were associated Q-glc production, putatively due to expression of alpha-rhamnosidases 341 
that can act on rutin. We also found that Lachnospiraceae (Lachnoclostridium and Eisenbergiella) 342 
were associated with Q production, which may be due to expression of beta-rutosidase enzymes or a 343 
combination of alpha-rhamnosidase and beta-glucosidase enzymes. 344 
 345 
According to our findings, we hypothesize that inter-individual variability in rutin metabolism is 346 
driven by differences in the composition of the gut microbiota. Variation in rutin and other flavonoid 347 
metabolisms in humans may also be caused by host and environmental factors as diet and genetic 348 
polymorphism and differences in enzymatic activity (Almeida et al., 2018). In conclusion, individual 349 
microbiotas exert distinct capability in rutin utilization, showing a higher response in certain 350 
individuals, whereas others seem less capable in rutin utilization. Future research that takes into 351 
account functional gene analysis, diet, and host physiology will advance our understanding of the 352 
role of the gut microbiota in rutin degradation and provide opportunities to improve human health. 353 
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Abbreviations: Q-glc, Quercetin-3-glucoside; Q, Quercetin; FACS, fluorescence activated cell 354 
sorting. 355 
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 485 
Figure legends: 486 
 487 
Figure 1. Schematic representation of rutin degradation. Rutin is present in a wide variety of foods. 488 
Rutin is not well-absorbed in the small intestine of humans, and thus is transported into the colon and 489 
metabolized by the gut microbiota into quercetin-3-glucoside and then quercetin or directly into 490 
quercetin. Quercetin may be subsequently degraded mainly into different phenolic acids. 491 
 492 
Figure 2. Levels of rutin, quercetin-3-glucoside (Q-glc) and quercetin (Q) after 0, 6 and 24 h 493 
incubation. (A-C) Box and whisker plots of the combined results of incubation of rutin with the gut 494 
microbiota of 10 participants, shown as peak areas obtained from LC-HRMS analysis. Open circles 495 
indicate results of abiotic controls. (D) Q-glc and (E) Q levels in each incubation after 6h and 24h.  496 
 497 
Figure 3. The rutin-stimulated microbiota. (A) Relative abundance of rutin-stimulated cells in 498 
incubations. (B) Representative microscopic images of samples from three participants showing 499 
variability in cell morphology between donors. Active cells are represented in red (BONCAT-Cy5) 500 
and all cells are stained in blue (DAPI). 501 
 502 
In evi
ew
 11 
Figure 4. Microbiota richness and diversity in rutin stimulated samples. (A) Observed ASVs, Chao1 503 
estimated richness, Shannon diversity, and inverse Simpson diversity estimators show significant 504 
difference between time points, active fraction and total community [ASVs richness, Chao1 and 505 
Shannon (ANOVA: p<0.0001, n=50), Inv. Simpson (ANOVA: p=0.020, n=50)]. Multiple 506 
comparisons are represented in the figure as asterisks. (B) NMDS ordination shows samples 507 
separation between the total community and the active fraction. 508 
 509 
Figure 5. Relative abundance of bacterial taxa based on 16S rRNA gene amplicon sequencing at 510 
family and genus level for each participant. (A, B) Relative abundance of the total community and 511 
the active fraction at time 6 and 24 h. (C, D) Relative abundance of the active fraction at time 6 or 24 512 
h. Family and genera with relative abundance >0.5% and >1%, respectively, is shown. 513 
 514 
Figure 6. Samples clusters based on rutin degradation pattern. Redundancy analysis shows sample 515 
clustering by degradation pattern in both the (A) total community (constrained variance 516 
explained:18.6%, RDA1 (14%), RDA2 (4.8%)) and (B) active fraction (constrained variance 517 
explained: 40.5%, RDA1 (36.3%), RDA2 (4.1%)) (C) Family-level heatmap showing the square root 518 
transformed relative abundance of the active fraction divided by producer groups at 24h. Significant 519 
changes in relative abundance (Low producers vs. High producers) are indicated with asterisks. 520 
Enterobacteriaceae increased in relative abundance in the High Q-glc producers. (High Q-glc 521 
producers vs. Low producers, p= 0.0055, High Q-glc producers vs. High-Q producers, p= 0.0061). 522 
Lachnospiraceae increased in relative abundance in the high-Q producers (High-Q producers vs. Low 523 
producers, p=0.0043, High-Q producers vs. High Q-glc producers, p<0.00001). 524 
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